These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15910946)

  • 21. Bronchial constriction after nebulized tobramycin preparations and saline in patients with cystic fibrosis.
    Nikolaizik WH; Jenni-Galović V; Schöni MH
    Eur J Pediatr; 1996 Jul; 155(7):608-11. PubMed ID: 8831087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Making antibiotic therapy easier to use. A welcome advance for those with cystic fibrosis].
    Sabourin G
    Perspect Infirm; 2011; 8(4):54-5. PubMed ID: 21812190
    [No Abstract]   [Full Text] [Related]  

  • 23. Glomerular and Tubular Renal Function after Repeated Once-Daily Tobramycin Courses in Cystic Fibrosis Patients.
    Stehling F; Büscher R; Grosse-Onnebrink J; Hoyer PF; Mellies U
    Pulm Med; 2017; 2017():2602653. PubMed ID: 28133546
    [No Abstract]   [Full Text] [Related]  

  • 24. Twice vs three-times daily antibiotics in the treatment of pulmonary exacerbations of cystic fibrosis.
    Adeboyeku D; Jones AL; Hodson ME
    J Cyst Fibros; 2011 Jan; 10(1):25-30. PubMed ID: 20920848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tobramycin inhalation powder: an efficient and efficacious therapy for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis.
    Somayaji R; Parkins MD
    Ther Deliv; 2015 Feb; 6(2):121-37. PubMed ID: 25690082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Budget impact model of tobramycin inhalation solution for treatment of Pseudomonas aeruginosa in cystic fibrosis patients.
    Woodward TC; Brown R; Sacco P; Zhang J
    J Med Econ; 2010; 13(3):492-9. PubMed ID: 20670159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pseudomonas infections in lungs of children born with cystic fibrosis. Effects and adverse effects during antibiotic therapy with tobramycin and carbenicillin].
    Friis B; Thomsen J
    Ugeskr Laeger; 1979 Jul; 141(29):1968-72. PubMed ID: 545764
    [No Abstract]   [Full Text] [Related]  

  • 28. High dosage tobramycin treatment of children with cystic fibrosis. Bacteriological effect and clinical ototoxicity.
    Thomsen J; Friis B
    Int J Pediatr Otorhinolaryngol; 1979 Jul; 1(1):33-40. PubMed ID: 553884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis.
    Hazinski TA
    J Pediatr; 1999 Jul; 135(1):130. PubMed ID: 10428654
    [No Abstract]   [Full Text] [Related]  

  • 30. [Inhalational antibiotic therapy in patients with cystic fibrosis and Pseudomonas infection].
    Mordasini C; Aebischer CC; Schoch OD
    Schweiz Med Wochenschr; 1997 May; 127(21):905-10. PubMed ID: 9289818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct comparison of in vitro susceptibility of wildtype clinical Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) to TOBI and BRAMITOB (tobramycin inhalation solutions).
    Moore JE; Maeda Y; Goldsmith CE; Rendall JC; Elborn JS
    J Cyst Fibros; 2010 May; 9(3):237-8. PubMed ID: 20378421
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhaled antibiotics.
    Tiddens H
    Pediatr Pulmonol Suppl; 2004; 26():92-4. PubMed ID: 15029611
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term tobramycin therapy in patients with cystic fibrosis and advanced pulmonary disease.
    Paporisz U; Posselt HG; Wönne R; Ristow W; Röser D; Knothe H; Bender SW
    Monogr Paediatr; 1979; 10():31-3. PubMed ID: 460275
    [No Abstract]   [Full Text] [Related]  

  • 34. Cystic fibrosis upper airways primary colonization with Pseudomonas aeruginosa: eradicated by sinonasal antibiotic inhalation.
    Mainz JG; Michl R; Pfister W; Beck JF
    Am J Respir Crit Care Med; 2011 Nov; 184(9):1089-90. PubMed ID: 22045752
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of pseudomonas infections in cystic fibrosis using tobramycin.
    McCrae WM
    Scott Med J; 1976 Apr; 21(2):68-9. PubMed ID: 940997
    [No Abstract]   [Full Text] [Related]  

  • 36. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis.
    Gibson RL; Emerson J; McNamara S; Burns JL; Rosenfeld M; Yunker A; Hamblett N; Accurso F; Dovey M; Hiatt P; Konstan MW; Moss R; Retsch-Bogart G; Wagener J; Waltz D; Wilmott R; Zeitlin PL; Ramsey B;
    Am J Respir Crit Care Med; 2003 Mar; 167(6):841-9. PubMed ID: 12480612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis].
    Canis F; Trivier D; Vic P; Ategbo S; Turck D; Husson MO
    Pathol Biol (Paris); 1998 Jun; 46(6):449-51. PubMed ID: 9769880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of inhaled tobramycin in patients with cystic fibrosis].
    Chermenskiĭ AG; Gembitskaia TE
    Ter Arkh; 2010; 82(8):76-8. PubMed ID: 20873251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled tobramycin: not just for cystic fibrosis anymore?
    Lobue PA
    Chest; 2005 Apr; 127(4):1098-101. PubMed ID: 15821180
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ochrobactrum anthropi bacteremia in a child with cystic fibrosis].
    Yagüe-Muñoz A; Gregori-Roig P; Valls-López S; Pantoja-Martínez J
    Enferm Infecc Microbiol Clin; 2010 Feb; 28(2):137-8. PubMed ID: 19811858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.